Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/19/2018 04/20/2018 04/23/2018 04/24/2018 04/25/2018 Date
147.1(c) 146.25(c) 148.33(c) 148.89(c) 151.71 Last
1 188 769 1 007 874 1 189 587 1 282 791 1 511 971 Volume
-1.46% -0.58% +1.42% +0.38% +1.89% Change
More quotes
Financials (USD)
Sales 2018 208 B
EBIT 2018 3 395 M
Net income 2018 1 493 M
Debt 2018 4 014 M
Yield 2018 0,83%
Sales 2019 214 B
EBIT 2019 3 746 M
Net income 2019 2 057 M
Debt 2019 3 887 M
Yield 2019 0,92%
P/E ratio 2018 19,23
P/E ratio 2019 14,77
EV / Sales2018 0,17x
EV / Sales2019 0,16x
Capitalization 30 606 M
More Financials
Company
McKesson Corp. is a health services and information technology company, which provides medicines, pharmaceutical and care management products.It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions.The McKesson Distribution Solutions segment distributes... 
Sector
Drug Retailers
Calendar
05/16Earnings Release
More about the company
Surperformance© ratings of McKesson Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on MCKESSON CORPORATION
04/25MCKESSON CORP : Costs Associated with Exit or Disposal Activities, Regulation FD..
AQ
04/25MCKESSON : Launches Comprehensive Review of Operations
DJ
04/25MCKESSON : Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 201..
BU
04/25POLARITYTE : Announces Appointment of McKessons Willie Bogan to Board of Directo..
AQ
04/24Glenview's Robbins says talk of Amazon's entering pharma is overblown
RE
04/23MCKESSON : Why the Future of Your Independent Pharmacy Depends on Patient Care
PU
04/21MCKESSON : Board of Directors Releases Findings, Recommendations of Independent ..
AQ
04/20MCKESSON : Board of Directors Releases Findings and Recommendations of Independe..
PU
04/19MCKESSON : Launches Health Mart Atlas
AQ
04/16Drug suppliers' shares rise as looming Amazon threat appears to ease
RE
More news
Sector news : Drug Retailers - NEC
04/24Glenview's Robbins says talk of Amazon's entering pharma is overblown
RE
04/23Humana, PE firms to buy hospice operator Curo Health for $1.4 billion
RE
04/20Generics group Alvogen puts Eastern European operations up for sale - sources
RE
04/17UnitedHealth earnings ease investor worries over flu season, stock up
RE
04/16Drug suppliers' shares rise as looming Amazon threat appears to ease
RE
More sector news : Drug Retailers - NEC
4-Traders Strategies on MCKESSON CORPORATION 
MCKESSON CORPORATION - 2012
An appropriate purchase level
BUY
MCKESSON CORPORATION - 2012
In oversold situation
BUY
More Strategies
Latest Tweets
01:29aMcKesson $MCK Releases FY18 Earnings Guidance  
12:48aMedical Specialties Distributors, LLC (MSD) Announced Today That It Has Enter.. 
04/25New Mountain Capital Agrees to Sell Medical Specialties Distributors to McKes.. 
04/25McKesson launches growth initiative, sees non-GAAP EPS as high as $12.80  
04/25McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 20.. 
More tweets
Qtime:173
News from SeekingAlpha
04/25McKesson launches growth initiative, sees non-GAAP EPS as high as $12.80 
04/24BY THE NUMBERS : Healthcare Stocks With Big Cash Distributions 
04/20Logos LP Q1 2018 Commentary - Long McKesson, Booking Holdings, Check Point So.. 
04/19McKesson - Deeply Undervalued 
04/16CNBC : Amazon kills plan to sell drugs to hospitals 
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 177 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
Britt Vitalone Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION-4.53%30 606
CVS HEALTH-9.41%66 634
WALGREENS BOOTS ALLIANCE-11.04%64 062
EXPRESS SCRIPTS HOLDING CO1.14%42 222
AMERISOURCEBERGEN-1.18%19 933
CARDINAL HEALTH1.55%19 581